Identification of immune responses that can provide protection against the adverse effects of malaria in pregnancy (ie, low birth weight, stillbirth, and maternal anemia [1] ) is essential for the rational development of new malaria control tools. Protective immunity has been suggested to be mediated by antibodies against VAR2CSA [2] , the variant antigen expressed on the surface of Plasmodium falciparum-infected erythrocytes that binds chondroitin sulfate A (CSA) to enable sequestration in the placenta [3] . The extracellular region of VAR2CSA contains 6 Duffy binding-like (DBL) domains [3] . Several of these DBL domains (DBL2X, DBL3X, DBL5ɛ, and DBL6ɛ) have been reported to bind to sulfated polysaccharides [4, 5] , although high and specific binding to CSA may depend on the folded architecture of multiple VAR2CSA domains [6] .
Antibodies against placental P. falciparum-infected erythrocytes and VAR2CSA domains develop after few infections during pregnancy [2, 7] , increase in levels with increasing parity [8] , and have been associated with a reduced risk of placental infection [2, 9] , low birth weight [10] [11] [12] , and maternal anemia [12, 13] .
Importantly, an association between antibodies to VAR2CSA and improved pregnancy outcomes was found in secundigravid women [10, 14] and women with chronic placental infections [11, 12] , but only few studies found these associations in all parity groups [15] . Moreover, several other studies failed to show a protective association [7, 13, [16] [17] [18] [19] [20] but instead suggested that antibodies at delivery reflect exposure to P. falciparum in pregnancy [8, 18, [21] [22] [23] [24] . These discrepancies may be partially explained by difficulties in distinguishing unexposed women from those who are exposed but protected by antiparasite immunity in areas of heterogeneous exposure to the parasite [25, 26] , as well as by differences in malaria transmission intensities and different overlapping distributions of malaria and human immunodeficiency virus (HIV) infection that provide varying opportunities for interactions between both conditions [27] [28] [29] .
This study examines the clinical relevance of immunoglobulin G (IgG) against VAR2CSA and other P. falciparum antigens in Mozambican pregnant women, as well as their relationship with HIV infection and factors that influence malaria exposure, such as parity, seasonality, neighborhood of residence, and intermittent preventive treatment during pregnancy (IPTp) [18, 23, 30] . To account for the effect of heterogeneous exposure to P. falciparum, the association between antibodies and pregnancy outcomes was also assessed in the subset of women with evidence of malaria during pregnancy, as recorded through passive morbidity surveillance at the antenatal care unit of a rural hospital in Mozambique.
MATERIALS AND METHODS

Study Population and Plasma Samples
Plasma samples collected at delivery from pregnant women participating in a randomized, double-blind, placebocontrolled trial of IPTp with sulfadoxine-pyrimethamine (SP; clinical trials registration NCT00209781) conducted in Manhiça (southern Mozambique) during 2003-2006 [31] were used for this study. In this semirural area, the climate is subtropical, with a warm, rainy season from November through April and a cool, dry season during the rest of the year. The Incomati River separates the sparsely inhabited flood plains and the flat plateau where Manhiça and surrounding villages are situated. Malaria transmission is perennial, with some seasonality and predominance of P. falciparum. At the time of the study, malaria control during pregnancy relied exclusively on case management.
After providing written informed consent, pregnant women at ≤28 weeks gestation received a long-lasting insecticidetreated net and were randomly assigned to receive SP or placebo. Maternal HIV type 1 status was determined with the Determine HIV-1/2 Rapid Test (Abbott Laboratories, North Chicago, IL) and confirmed with the Unigold rapid test (Trinity Biotech, Bray, Ireland). CD4 + T-cell counting was performed after staining fresh whole blood samples with labeled antibodies specific for CD4, CD3, CD8, and CD45 in TruCount tubes (Becton Dickinson Biosciences). At delivery, peripheral blood samples collected into vacutainers containing ethylenediaminetetraacetic acid were centrifuged, and plasma was stored at −20°C. Thin and thick smears of peripheral blood were Giemsa stained and examined for malarial parasites, according to quality-control procedures [32] . Tissue samples obtained from the maternal side of the placenta were processed for histological examination, and findings were classified as negative for P. falciparum infection or positive for acute, chronic, or past P. falciparum infections [33] . The birth weight of newborns was measured, gestational age was assessed by the Dubowitz method, and maternal hematocrit was quantified in a microcapillary tube. Malaria episodes, defined on the basis of a P. falciparum-positive blood smear and an axillary temperature ≥37.5°C and/or fever reported within the previous 24 hours, were detected in women from recruitment to delivery, through a health facility-based, passive surveillance system established at the Manhiça District Hospital. Uncomplicated malaria episodes were treated according to national guidelines with chloroquine or SP in the first and subsequent trimesters, respectively, and parenteral quinine was administered for severe malaria. 
Measurement of Antibodies Against Recombinant Antigens
Recombinant merozoite surface protein-1 (MSP-1 19 ; 19-kD fragment, 3D7 strain) [34] , erythrocyte-binding antigen-175 (EBA-175; region F2, Camp strain) [35] , apical membrane antigen-1 (AMA-1; full ectodomain, 3D7 strain) [36] , DBLα (CR1-binding minimal domain of the erythrocyte membrane protein 1 expressed by P. falciparum R29-rosetting + line) [37] , DBL3γ domain of VAR1CSA (FCR3 strain) [38] , and VAR2CSA domains (DBL3X [38] , DBL2X, DBL5ɛ, and DBL6ɛ from the 3D7 strain) were produced in Escherichia coli, refolded if the protein was insoluble, and purified ( purity, >95%) following previously described methods [35] . Enzyme-linked immunosorbent assay plates were coated with 200 ng of recombinant antigen per well and sequentially incubated with 100 µL of plasma (dilution, 1:500) in duplicate and secondary goat antihuman IgG peroxidase-conjugated antibody (dilution, 1:30 000) [18] . Reactions were developed as described previously [18] , and optical densities (ODs) were determined at 492 nm. Fifteen plasma samples from pregnant Spanish women who had never been exposed to malaria were used as negative controls. A pool of plasma samples from 10 multigravid, pregnant Mozambican women was used to normalize the data from different assays by multiplying ODs in each experiment by the ratio between the value of the positive control in first experiment and the value in subsequent experiments [18] .
Measurement of Antibodies Against the Surface of P. falciparum-Infected Erythrocytes
Cryopreserved O + erythrocytes infected by two placental isolates (Plac1 and Plac2) and 2 pediatric isolates (Ch1 and Ch2) from Manhiça [23] were thawed and matured to trophozoite stage without in vitro expansion. Erythrocytes at 1% hematocrit were sequentially incubated with test plasma (1:20) , rabbit anti-human IgG (1:200) and AlexaFluor donkey anti-rabbit IgG (1:1000) plus 10 µg/mL of ethidium bromide. Reactivity against the surface of P. falciparum-infected erythrocytes was expressed as the difference between the mean fluorescence intensity (MFI) of 1000 P. falciparum-infected erythrocytes and the MFI of uninfected erythrocytes obtained in a FACSCalibur flow cytometer. The pool of plasma samples from 10 Mozambican pregnant women was used to normalize the data from different assays as described above [18] .
Definitions and Statistical Methods
Pregnant women were classified into those having a first pregnancy ( primigravidae), those having a second pregnancy (secundigravidae), and those with at least 2 previous pregnancies (multigravidae). Age was categorized as ≤20, 21-24, and ≥25 years on the basis of maternal age terciles in this population. Distance to the river was calculated with Hawth's tools in ArcGIS software (ESRI) as the mean distance of each neighborhood centroid to the river, and neighborhoods were classified as close to the river (distance ≤2.5 km [ie, median distance from neighborhoods that are adjacent to the river]) or far from the river (>2.5 km). The season during pregnancy was defined as dry if the period of gestation included the 6 cool dry months (May through October) and as rainy if it included ≥4 rainy months (November through April). The breadth of recognition [9, 39] was defined as the number of antigens being recognized by each plasma specimen tested (ie, an OD or MFI above the mean plus 3 SDs of the values obtained with the plasma specimens from the 15 negative control subjects [18] ). Proportions were compared by the Fisher exact test, and normally distributed values were compared by the Student t test. The association between maternal infection at delivery, parity, neighborhood, season, and IPTp and log-transformed ODs or MFIs, as well as association between maternal hematocrit, weight, and gestational age of the newborn and high antibody responses (ie, an OD or MFI above the median values of all samples measured [11] ) were evaluated by linear regression models. To assess whether HIV infection or exposure during pregnancy (ie, having had a malaria episode during pregnancy) modified the associations, an interaction term was included in the regression models, and ratios and 95% confidence intervals (CIs) for each antibody responses were estimated after stratifying the regression models. Data were analyzed with Stata, version 11.0 (Stata). P values of <.05 were considered statistically significant.
RESULTS
Characteristics of Pregnant Women
The analysis of antibody responses included 293 of 300 women who were initially selected, as peripheral plasma samples from 7 women were not available. 
Association of Antibody Levels With Maternal Infection
Compared with uninfected women, women with acute, chronic, or past placental infection had higher levels of IgG against all parasite and recombinant antigens tested ( Figure 1 ) and a higher breadth of recognition (adjusted rate ratio [aRR], 1.59; 95% CI, 1.44-1.77; P < .001). IgG levels were not associated with peripheral infection when the analysis was adjusted for placental infection (data not shown). 
Association of Antibody Levels With Factors Influencing Parasite Exposure
To determine whether variations in exposure to P. falciparum affect antibodies in pregnant women, the association of IgG responses in women at delivery with season, neighborhood, parity, and use of IPTp was assessed. Levels of IgG against both placental isolates and DBL6ε, as well as the breadth of recognition (aRR, 1.16; 95% CI, 1.02-1.32; P = .027), were higher in women residing in areas close to the river (≤2.5 km) than in women living far from the river (Figure 2 ). Season was not found to affect levels of IgG nor breadth of recognition, except for IgG levels against DBL6ε, which were lower in women who were pregnant during the dry season than in women who were pregnant during the rainy season (ratio of mean IgG levels by season, 0.83; 95% CI, .71-.97; P = .020). Similarly, IPTp did not show any effect on the breadth of recognition (aRR, 0.93; 95% CI, .82-1.04; P = .209). IgG levels against several of the antigens were found to increase with parity of the women without placental infection [23] (analysis adjusted for age; Figure 3 ), whereas an increase was not found among women with placental infection. HIV-infected women who were pregnant during the rainy season had higher antibody levels against 1 placental isolate (ratio of mean IgG levels by season, 3.44; 95% CI, 1.56-7.69; P = .003), DBLγ (ratio, 3.33; 95% CI, 1.64-6.67; P = .002), DBL3X (ratio, 3.22; 95% CI, 1.18-9.09; P = .026), and a higher breadth of recognition (aRR, 1.82; 95% CI, 1.15-2.86; P = .011), compared with HIV-infected women who were pregnant during the dry season. Similarly, HIV-infected women who received placebo had higher levels of IgG against 2 placental isolates and one of the pediatric isolates (Supplementary Table 1 ) and a higher breadth of recognition (aRR, 1.39; 95% Figure 2 . Immunoglobulin G (IgG) levels in pregnant women living close to (≤2.5 km) or far from (>2.5 km) the river. Geometric mean IgG levels (mean fluorescence intensity for placental [Plac] and pediatric [Ch] isolates and optical density for recombinant proteins) and 95% confidence intervals by women close to (n = 62) or far from (n = 231) from the river are indicated by horizontal lines. P values were obtained from the univariate (P*) and multivariate linear regression analysis adjusted for parity, age, human immunodeficiency virus infection status, season, and intermittent preventive treatment during pregnancy (P**). P for the second placental isolate (not shown in the figure): P * = .008; P ** = .027.
CI, 1.1-1.72; P = .006), compared with HIV-infected women who received SP. In contrast, the breadth of recognition was similar in HIV-negative women, regardless of the season (aRR, 0.94; 95% CI, .81-1.09; P = .435) and having received SP or placebo (aRR, 1.03; 95% CI, .89-1.18; P = .739).
Antibody levels among HIV-negative women without placental infection increased with parity, but no evidence of such association was found among HIV-infected women ( Table 2) . The association between antibody levels and parity among women with placental infection was not modified by HIV infection.
Association of Antibody Levels With Pregnancy Outcomes
No association was found between improved pregnancy outcomes and antibody responses among all pregnant women included in the study. Instead, high IgG levels against one of the placental and pediatric isolates, DBL2X, EBA175, and DBLα were found to be related to lower weights and/or gestational ages of the newborns, as well as to a lower maternal hematocrit in the case of DBLα (Table 3) . Stratification by parity group did not show any association between improved pregnancy outcomes and antibody responses (Supplementary Table 2 ).
To reduce the confounding effect of heterogeneous malaria exposure, associations of antibody responses with pregnancy outcomes were assessed among pregnant women with proven malaria exposure during pregnancy (ie, those with at least 1 malaria episode during pregnancy). This analysis showed that high IgG levels against one of the placental isolates, one of the pediatric isolates, AMA1, DBL3X, and DBL6ε were associated with increased birth weight and gestational age of the newborns (Figure 4) . The multivariate analysis showed that mean differences in birth weight between women with high and those with low antibody levels were 918 g (95% CI, 336-1499) for Ch2, 959 g (95% CI, 326-1591) for Plac2, 936 g (95% CI, 505-1366) for DBL3X, and 921 g (95% CI, 488-1356) for DBL6ε, and mean differences in gestational age were 1.99 weeks (95% CI, .32-3.66) for Ch2, 1.96 weeks (95% CI, .73-3.2) for DBL3X, and 2.69 weeks (95% CI, .41-4.96) for AMA1. However, such associations were not found among mothers with no malaria episode recorded during pregnancy (Supplementary Figure 1) . and multivariate linear regression analysis, using primigravidae women as the reference group, and were adjusted for age, human immunodeficiency virus infection status, season, neighborhood, and intermittent preventive treatment during pregnancy (P **). P for the second placental isolate (not shown in the figure): P * = .029; P ** = .003.
Overall, having had a malaria episode before delivery modified the association of maternal antibody responses with birth weight (P for interaction: placental isolate, .016; pediatric isolate .011; DBL3X, < .001; and DBL6ε, .001) and gestational age of the newborns (P for interaction: AMA1, .006; DBL3X, .028; and DBL6ε, .043).
DISCUSSION
This study shows that antibody responses reflect temporal and geographical variations in the exposure to P. falciparum [9, 20, 40] and that these heterogeneities need to be taken into account to assess the clinical impact of antibody responses against malaria during pregnancy. No association was found between antibody responses and improved pregnancy outcomes when all women, independently of their level of exposure, were included into the analysis. However, positive associations emerged when only women with proven P. falciparum infection before delivery (ie, those with a malaria episode during pregnancy) were considered for the analysis. Although passive detection of malaria episodes during pregnancy missed asymptomatic infections, this approach probably reduced the confusion caused by the inclusion of women with favorable pregnancy outcomes but low antibody levels due to a lack of parasite exposure.
Results of this study show how the power to estimate immune correlates of protection in pregnant women with heterogeneous intensities of malaria transmission can be reduced by inclusion of pregnant women with different degrees of exposure [41] . The confounding effect of exposure was not removed after adjustment by parity, proximity to the river, season during pregnancy, and use of IPTp. This is probably due to the existence of microheterogeneities in P. falciparum transmission that are not captured by these variables, as has been shown to happen in studies assessing the association between antibody responses to blood-stage antigens in children and the risk of clinical malaria [41] . Associations were only observed after stratifying the analysis on the basis of having had a clinical malaria episode during pregnancy. Among women with an episode, several antibody responses (against a pediatric and a placental isolate, DBL3X, DBL6ε, and AMA1) were associated with improved pregnancy outcomes. In contrast, high levels of antibodies against a placental isolate and DBL3X among women who did not report a malaria episode were associated with an increased risk of poor pregnancy outcomes, possibly because these antibodies were developed after an asymptomatic infection during pregnancy that negatively impacted the health of the newborn, in contrast to unexposed women with low antibodies and favourable pregnancy outcomes. These results Twenty-three primigravidae were HIV negative, and 5 were HIV positive; 25 secundigravidae were HIV negative, and 9 were HIV positive; and 71 multigravidae were HIV negative, and 14 were HIV positive.
Abbreviations: Ch, pediatric isolates; CI, confidence interval; Plac, placental isolates. a Defined as the ratio of the mean immunoglobulin G (IgG) level for secundigravid and multigravid women to the mean IgG level for primigravid women. The linear regression model was adjusted for age, season, neighborhood, and intermittent preventive treatment during pregnancy.
highlight the importance of developing additional methods to adjust for heterogeneity in parasite exposure when assessing immune responses that contribute to protection against malaria infection in pregnancy [25] . This study demonstrates that not only active P. falciparum infection in the placenta [23] but also past placental infections, as defined by the presence of only hemozoin in placental sections at delivery, are associated with an increase in levels of IgG against VAR2CSA and other blood-stage antigens, including variant surface antigens expressed by placental and pediatric isolates. High levels of antiparasite antibodies in women at delivery may thus be markers of cumulative exposure to P. falciparum during pregnancy. Consistent with this interpretation, antibody levels against P. falciparum antigens were found to be affected by factors that influence exposure to malaria, such as parity and area of residence [18, 42] , which is similar to what has been reported for use of insecticide-treated nets [43] . These factors were independent of the HIV infection status of pregnant women, possibly because of their strong effect on antibody responses, in contrast to the effects of seasonality and IPTp, which depended on HIV infection status in pregnant women.
HIV infection not only reduces antibody levels against P. falciparum antigens in pregnant women [28] but can also affect the relationships between these antibodies and determinants of malaria exposure. HIV infection was found to attenuate the parity-dependent increased levels of antibodies against placental and pediatric isolates, VAR2CSA domains, and merozoite antigens [23] observed in HIV-negative women. A longer duration of HIV infection in multigravidae, as suggested by their lower CD4 + T-cell counts as compared to those for primigravidae, may have impaired T-cell and B-cell memory pools responsible for the maintenance of antibody production [44, 45] , explaining why no evidence of such an increase with parity was found among HIV-infected women. Although the absence of a statistically significant difference is not proof of no association, a waning of antibody levels in HIV-infected immunosuppressed women [44, 46] may contribute to the increased risk of malaria associated with HIV infection that has been observed in multigravidae as compared to primigravid [29] , as well as to the accelerated decay of antibody levels in the absence of parasite exposure (ie, during seasons of low malaria transmission or IPTp treatment). In contrast, HIV-negative women may maintain elevated levels of antibodies for longer periods [47] , overcoming fluctuations in parasite exposure associated with seasonality or the use of effective malaria control tools, such as IPTp [18] . The results of this study show associations between improved pregnancy outcomes and antibody responses against VAR2CSA (DBL3X and DBL6ε), parasite isolates expressing other variant surface antigens and merozoite antigen AMA1 in women with proven exposure to P. falciparum. This is in contrast to previous studies that pointed toward an exclusive role for antibodies against VAR2CSA in the reduction of the adverse effects of malaria in pregnancy [2, 9, 10, 12] , and suggests that immune responses against parasite antigens other than those specifically associated to pregnancy (ie, VAR2CSA) may also contribute to reduce the risk of poor pregnancy outcomes. Alternatively, these antibody responses may be surrogates of other effective immune responses not assessed in this study. Importantly, antibodies were not associated with changes in maternal hematocrit, suggesting that other mechanisms may be involved in reducing the risk of anemia. More prospective studies using plasma samples collected from pregnant women in the early stages of pregnancy [15] and measurement of antibodies to other principal immunogenic domains, such as DBL4ε [48] , not tested in this study are needed to identify immune responses associated with a reduced risk of poor pregnancy outcomes.
In conclusion, this study shows that antibody responses to P. falciparum in pregnant women are affected by variables that influence the risk of exposure to P. falciparum, such as parity, season, and neighborhood. HIV infection modifies these associations between exposure and antibody responses, probably through its impact on the maintenance of IgG responses. Reducing the confounding effect of heterogeneous malaria exposure through exclusion of women who did not show evidence of P. falciparum infection during pregnancy allowed the identification of clinically-relevant antibody responses that may reduce the adverse effects of malaria in pregnancy. Figure 4 . Pregnancy outcomes, by low and high antibody levels, in women with a malaria episode during pregnancy. Geometric mean weight and gestational age and 95% confidence intervals are indicated by horizontal lines. Plasma samples with high immunoglobulin G levels were those having an optical density or mean fluorescence intensity above the median values of all samples measured. P values were obtained from the univariate (P *) and multivariate linear regression analysis adjusted for parity, age, human immunodeficiency virus infection status, and intermittent preventive treatment during pregnancy (P **). N refers to the number of observations in each group.
